Gatilox DM Sterile Eye Drops

Introduction

Gatilox DM Steriles is a prescription medication that contains two active ingredients: Dexamethasone and Gatifloxacin. It is available under the brand name Gatilox DM Steriles. This medication is primarily used to treat inflammatory conditions and bacterial infections of the eye.

Uses

Gatilox DM Steriles is commonly prescribed for the following conditions:

• Eye inflammation: Gatilox DM Steriles helps reduce inflammation in the eye caused by various conditions, such as allergic conjunctivitis, uveitis, and postoperative inflammation.
• Bacterial eye infections: This medication is effective against certain types of bacterial infections that affect the eye, including conjunctivitis and keratitis.

Please note that Gatilox DM Steriles is intended for use in the eye only and should not be used for any other conditions without the guidance of a healthcare professional.

Dosage and Administration

To use Gatilox DM Steriles, follow these general dosage instructions:

• Wash your hands thoroughly before using the eye drops.
• Tilt your head back slightly and pull down your lower eyelid to create a small pocket.
• Hold the dropper bottle close to your eye and squeeze the prescribed number of drops into the pocket formed by the lower eyelid. Avoid touching the dropper tip to any surface to prevent contamination.
• Close your eye gently and blink a few times to spread the medication evenly across the eye.
• If you are using other eye medications, wait at least 5 minutes between applying each medication to prevent interactions.

The exact dosage and frequency of use will be determined by your healthcare provider based on the severity of your condition. Follow their instructions carefully.

Mechanism of Action

Gatilox DM Steriles combines two active ingredients with different mechanisms of action to provide a comprehensive treatment approach:

• Dexamethasone: This medication belongs to a class of drugs called corticosteroids. Dexamethasone works by reducing inflammation in the eye by suppressing the release of substances that cause inflammation. It also helps to relieve itching, redness, and swelling.
• Gatifloxacin: Gatifloxacin is a fluoroquinolone antibiotic that works by inhibiting the growth and multiplication of bacteria. It effectively kills or stops the growth of bacteria that cause eye infections, helping to alleviate the symptoms and promote healing.

Side Effects

Common side effects may include:

• Mild stinging or burning sensation in the eyes
• Temporary blurred vision
• Itching or redness of the eyes
• Dry eyes

If any of these side effects persist or worsen, contact your healthcare provider for further guidance. In rare cases, serious side effects such as eye pain, vision changes, or signs of an allergic reaction may occur. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare provider about all the medications you are currently taking, including prescription and over-the-counter drugs, as well as any herbal supplements or vitamins. Drug interactions may occur when certain medications interact with each other and can affect the safety and effectiveness of the treatment. Some common and serious drug interactions with Gatilox DM Steriles include:

• Other corticosteroid medications
• Other antibiotics
• Eye drops containing similar active ingredients

To ensure your safety, follow your healthcare provider’s instructions and inform them about all the medications you are using.

Precautions

Before using Gatilox DM Steriles, consider the following precautions:

• Inform your healthcare provider if you are allergic to dexamethasone, gatifloxacin, or any other medications.
• Discuss any medical conditions you have, especially if you have a history of glaucoma or other eye conditions, diabetes, or any infections.
• Inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as Gatilox DM Steriles may not be suitable for use during pregnancy or while breastfeeding.
• Avoid touching the dropper tip to any surface to prevent contamination.
• If you experience any allergic reactions, such as itching, swelling, or difficulty breathing, discontinue use and seek immediate medical attention.

Storage

To ensure the potency and safety of Gatilox DM Steriles, store it properly:

• Keep the medication in its original container with the cap tightly closed.
• Store it at room temperature, away from direct sunlight, heat, and moisture.
• Keep it out of reach of children and pets.
• Do not use the eye drops if they have expired or if the liquid has changed in color or consistency.

Patient Tips

• Follow the prescribed dosage and administration instructions provided by your healthcare provider.
• If you wear contact lenses, remove them before using the eye drops. Wait at least 15 minutes before reinserting the lenses.
• Avoid touching your eyes with unwashed hands to prevent the spread of infection.
• If you experience any discomfort or worsening of symptoms, contact your healthcare provider.
• Attend regular follow-up appointments with your healthcare provider to monitor the effectiveness of the treatment.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• PIP breast implants (NHS UK) [Accessed 1 Jun. 2024] (online) Available at:
• Dexafree (Health Professionals SmPC) Available at:
• Dexamethasone (Drugs.com) [Accessed 19 Jun. 2024] (online) Available at:
• dexamethasone (RX) [Accessed 17 Jun. 2024] (online) Available at:
• Intravitreal injection (MedlinePlus) [Accessed 11 Jun. 2024] (online) Available at:
• Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM; Ozurdex MEAD Study Group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology. 2014 Oct;121(10):1904-14. doi: 10.1016/j.ophtha.2014.04.024. Epub 2014 Jun 4. [Accessed 29 Jun. 2024] Available at: